Anthony Rodgers's Publications

About Anthony Rodgers's Publications

Professorial Fellow, Professoriate
  • Professor of Global Health, Faculty of Medicine, UNSW Sydney
  • Chair of Clinical Epidemiology, Faculty of Medicine, Imperial College of London
  • Effects of Low-dose Triple Combination Therapy on Time at Target Blood Pressure - Results From the TRIUMPH Randomized Controlled Trial

    Heart, Lung and Circulation Date published:
  • Patient Acceptability of Polypill Treatment for Hypertension: A Qualitative Study From the QUARTET Trial

    Heart, Lung and Circulation Date published:
  • Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine

    AIDS Date published:
  • Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019

    Journal of the American College of Cardiology Date published:
  • Cardiovascular preventive strategies are not conflicting

    The Lancet Date published:
  • Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension

    JAMA Cardiology Date published:
  • Association between comorbidities and blood pressure trajectories in patients with hypertension

    European Heart Journal Date published:
  • Preferences for Tobacco Cessation Information and Support During Covid-19

    Journal of Addiction Medicine Date published:
  • A digital health intervention for cardiovascular disease management in primary care (CONNECT) randomized controlled trial

    npj Digital Medicine Date published:
  • Two-drug fixed-dose combinations of blood pressure-lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost

    The Journal of Clinical Hypertension Date published:
  • Regression to the mean in home blood pressure: Analyses of the BP GUIDE study

    The Journal of Clinical Hypertension Date published:
  • Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

    Journal of the American Heart Association Date published:
  • Optimising TRIUMPH with 6·25 mg chlorthalidone - Authors' reply

    The Lancet Global Health Date published:
  • Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants

    The Lancet Diabetes & Endocrinology Date published:
  • 471 Cumulative Benefits of Cholesterol Lowering for the Prevention of Cardiovascular Events

    Heart, Lung and Circulation Date published:
  • The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program

    The Lancet Rheumatology Date published: